BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26621455)

  • 1. The expression of CD44v6 in colon: from normal to malignant.
    Afify A; Durbin-Johnson B; Virdi A; Jess H
    Ann Diagn Pathol; 2016 Feb; 20():19-23. PubMed ID: 26621455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.
    Krishn SR; Kaur S; Smith LM; Johansson SL; Jain M; Patel A; Gautam SK; Hollingsworth MA; Mandel U; Clausen H; Lo WC; Fan WT; Manne U; Batra SK
    Cancer Lett; 2016 May; 374(2):304-14. PubMed ID: 26898938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD44v6 is associated with cellular dysplasia in colorectal epithelial cells.
    Orzechowski HD; Beckenbach C; Herbst H; Stölzel U; Riecken EO; Stallmach A
    Eur J Cancer; 1995 Nov; 31A(12):2073-9. PubMed ID: 8562168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44V6 expression in human colorectal carcinoma.
    Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS
    Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
    Ho SB; Ewing SL; Montgomery CK; Kim YS
    Oncol Res; 1996; 8(2):53-61. PubMed ID: 8859775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.
    Wang L; Liu Q; Lin D; Lai M
    Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Sonic hedgehog pathway genes is altered in colonic neoplasia.
    Oniscu A; James RM; Morris RG; Bader S; Malcomson RD; Harrison DJ
    J Pathol; 2004 Aug; 203(4):909-17. PubMed ID: 15258993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEA in colonic adenocarcinomas and precancerous lesions. An immunohistochemical study with a novel monoclonal antibody.
    Tormo BR; Gavilondo JV; Dominguez C; Freyre M; Rodriguez T; Biberfeld P
    APMIS; 1989 Dec; 97(12):1073-80. PubMed ID: 2611022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of FAT10 in colon benign, premalignant and malignant epithelial neoplasms.
    Qing X; French BA; Oliva J; French SW
    Exp Mol Pathol; 2011 Feb; 90(1):51-4. PubMed ID: 20888811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
    Afify AM; Craig S; Paulino AF; Stern R
    Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model for human colon carcinoma evolution based on the differential response of cultured preneoplastic, premalignant, and malignant cells to 12-O-tetradecanoylphorbol-13-acetate.
    Friedman E; Urmacher C; Winawer S
    Cancer Res; 1984 Apr; 44(4):1568-78. PubMed ID: 6423277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of tumor-associated glycoprotein DF3 in normal, inflammatory, and neoplastic lesions of the colon.
    Andrews CW; Jessup JM; Goldman H; Hayes DF; Kufe DW; O'Hara CJ; Steele GD
    Cancer; 1993 Dec; 72(11):3185-90. PubMed ID: 7694786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast.
    Afify A; McNiel MA; Braggin J; Bailey H; Paulino AF
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):121-7. PubMed ID: 18227732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of difucosyl type 2 chain (LeY) defined by monoclonal antibody AH6 in different locations of colonic epithelia, various histological types of colonic polyps, and adenocarcinomas.
    Abe K; Hakomori S; Ohshiba S
    Cancer Res; 1986 May; 46(5):2639-44. PubMed ID: 3516384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bimodal expression of heparin-binding EGF-like growth factor in colonic neoplasms.
    Ito Y; Higashiyama S; Takeda T; Okada M; Matsuura N
    Anticancer Res; 2001; 21(2B):1391-4. PubMed ID: 11396220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids.
    Afify A; Pang L; Howell L
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):446-50. PubMed ID: 18091389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal eosinophilia in colonic epithelial neoplasms.
    Moezzi J; Gopalswamy N; Haas RJ; Markert RJ; Suryaprasad S; Bhutani MS
    Am J Gastroenterol; 2000 Feb; 95(2):520-3. PubMed ID: 10685761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression.
    Zhao LH; Lin QL; Wei J; Huai YL; Wang KJ; Yan HY
    Int J Clin Exp Pathol; 2015; 8(1):692-701. PubMed ID: 25755763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic chicken-skin mucosa in children with polyps is not a preneoplastic lesion.
    Nowicki MJ; Bishop PR; Subramony C; Wyatt-Ashmead J; May W; Crawford M
    J Pediatr Gastroenterol Nutr; 2005 Nov; 41(5):600-6. PubMed ID: 16254516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ets-1 and ets-2 in colonic neoplasms.
    Ito Y; Takeda T; Okada M; Matsuura N
    Anticancer Res; 2002; 22(3):1581-4. PubMed ID: 12168840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.